Ferring Pharmaceuticals Secures Preferred Access for Orthopaedic & Gastroenterology Treatments Through CVS Health and Aetna Pharmacy Benefit
Posted December 18th, 2020 for Ferring Pharmaceuticals Parsippany, NJ – December 18, 2020 – Beginning January 1, 2021, Ferring Pharmaceuticals will gain preferred access through CVS Health and Aetna formularies for EUFLEXXA ® (1% sodium hyaluronate) for the treatment of knee osteoarthritis (OA) pain and exclusive preferred access on three out of four formularies for CLENPIQ ® (sodium picosulfate, magnesium oxide, and anhydrous citric acid) oral solution for cleansing of the colon a...
United States Brent Ragans Heather Guzzi Ferring Pharmaceuticals Ferring Pharmaceuticals Us We Beginning January
Source: pressreleasepoint.com